Hormones – Cytokines – Signalling
Kidney International (2005) 67, 875–885; doi:10.1111/j.1523-1755.2005.00152.x
Purinergic modulation of mesangial extracellular matrix production: Role in diabetic and other glomerular diseases
ANNA SOLINI, CARLA IACOBINI, CARLO RICCI, PAOLA CHIOZZI, LORENA AMADIO, FLAVIA PRICCI, UMBERTO DI MARIO, FRANCESCO DI VIRGILIO and GIUSEPPE PUGLIESE
Department of Internal Medicine, University of Pisa, Pisa, Italy; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy; Department of Clinical Sciences, "La Sapienza" University, Rome, Italy; Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; and Interdisciplinary Center for the Study of Inflammation, University of Ferrara, Ferrara, Italy
Correspondence: Giuseppe Pugliese, M.D., Ph.D., Dipartimento di Scienze Cliniche (Endocrinologia), Viale del Policlinico, 155–00161 Rome, Italy. E-mail:giuseppe.pugliese@uniroma1.it
Received 7 February 2004; Revised 24 June 2004; Re-revised 23 September 2004; Accepted 30 September 2004.
Abstract
Purinergic modulation of mesangial extracellular matrix production: Role in diabetic and other glomerular diseases.
Background
Extracellular adenosine triphosphate (ATP) (eATP) mediates several biologic activities via purinergic P2 receptors (P2Rs). This study aimed at (1) evaluating the role of the purinergic system in modulating mesangial extracellular matrix (ECM) and transforming growth factor-
(TGF-) production and (2) its contribution to diabetes-induced mesangial ECM accumulation.
Methods
Rat mesangial cells were grown in normal glucose (5.5 mmol/L) or high glucose (30 mmol/L) containing media and probed with purinergic agonists and antagonists for the assessment of the expression pattern and function of P2Rs; release of ATP and activity of ectoATPases; and changes in ECM and TGF- expression.
Results
Cells cultured in normal glucose and high glucose expressed similar amounts of functional P2Rs of the P2X2, P2X3, P2X4, P2X5, P2X7, P2Y1, P2Y2, P2Y4, and P2Y6 subtypes. Levels of eATP were higher in high glucose vs. normal glucose, with unchanged ectoATPase activity. The ATP-hydrolyzing enzymes hexokinase or apyrase reduced ECM and TGF- production from cells grown in high glucose, but not normal glucose. Under both normal glucose and high glucose conditions, ATP and the P2X7 agonist benzoylbenzoylATP increased dose-dependently ECM and TGF- production, whereas the P2Y agonist uridine triphosphate (UTP) produced the opposite effect. The P2X7 inhibitor oxidized ATP attenuated the ECM and TGF- up-regulation induced by ATP and, to a lesser extent, that caused by high glucose. A TGF- neutralizing antibody also prevented ATP-induced ECM up-regulation.
Conclusion
These data indicate a role for eATP in regulating ECM production via TGF- and suggest that P2XRs and P2YRs differentially modulate this process. An increased ATP release induced by hyperglycemia might contribute to mesangial matrix expansion occurring in diabetes.
Keywords:
extracellular ATP, purinergic receptors, mesangial cell, extracellular matrix, diabetic nephropathy
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Purinergic signalling and disorders of the central nervous system
Nature Reviews Drug Discovery Review (01 Jul 2008)
NEWS AND VIEWS
Nucleotides and cd39: Principal modulatory players in hemostasis and thrombosis
Nature Medicine News and Views (01 Sep 1999)
RESEARCH
Role of P2X7 Receptors in Ischemic and Excitotoxic Brain Injury In Vivo
Journal of Cerebral Blood Flow & Metabolism Original Article
Journal of Investigative Dermatology Original Article
Glomerular expression of the ATP-sensitive P2X7 receptor in diabetic and hypertensive rat models
Kidney International Original Article
